Cwm, LLC Ocular Therapeutix, Inc Transaction History

Cwm, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Sep 15, 2021	BUY	$3.95 - $7.4 $7,900 - $14,800	2,000 New	2,000 $28,000
Q1 2020 Apr 28, 2020	SELL	$3.95 - $7.4 $7,900 - $14,800	-2,000 Closed	0 $0
Q4 2019 Sep 14, 2021	SELL	$2.57 - $4.73 $2,570 - $4,730	-1,000 Reduced 33.33%	2,000 $28,000
Q4 2019 Jan 27, 2020	BUY	$2.57 - $4.73 $2,570 - $4,730	1,000 Added 50.0%	3,000 $12,000
Q3 2019 Sep 14, 2021	BUY	$3.04 - $5.32 $6,080 - $10,640	2,000 New	2,000 $28,000

Q3 2019 Oct 22, 2019	SELL	$3.04 - $5.32 $6,080 - $10,640	-2,000 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$2.46 - $4.52 $4,920 - $9,040	2,000 New	2,000 $28,000
Q2 2019 Jul 31, 2019	SELL	$2.46 - $4.52 $4,920 - $9,040	-2,000 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$3.51 - $4.77 $7,020 - $9,540	2,000 New	2,000 $0

148

123M

185K

507K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $514M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwm, LLC with notifications on news.